Skip to main content

and
  1. Article

    Open Access

    MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets

    c-MYC (MYC) is a major driver of prostate cancer tumorigenesis and progression. Although MYC is overexpressed in both early and metastatic disease and associated with poor survival, its impact on prostate tran...

    **ntao Qiu, Nadia Boufaied, Tarek Hallal, Avery Feit, Anna de Polo in Nature Communications (2022)